Lck Polyclonal Antibody

货号：ES6096
价格：面议
点击：1918

产品介绍

抗体信息

应用	WB;IHC-p;IF/ICC;ELISA
反应种属	Human;Mouse;Rat
别称	LCK; Tyrosine-protein kinase Lck; Leukocyte C-terminal Src kinase; LSK; Lymphocyte cell-specific protein-tyrosine kinase; Protein YT16; Proto-oncogene Lck; T cell-specific protein-tyrosine kinase; p56-LCK

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Isatuximab Non-Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗非中和重组抗体(靶标：艾沙妥昔单抗非中和抗体)	210
Anti-Isatuximab Non-Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗非中和重组抗体(靶标：艾沙妥昔单抗非中和抗体)	447
Anti-Isatuximab Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗中和重组抗体(靶标：艾沙妥昔单抗中和抗体)	350
Anti-Isatuximab Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗中和重组抗体(靶标：艾沙妥昔单抗中和抗体)	172
Anti-Isatuximab Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗中和重组抗体(靶标：艾沙妥昔单抗中和抗体)	138
Anti-Urelumab Non-Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗非中和重组抗体(靶标：乌瑞鲁单抗非中和抗体)	447
Anti-Urelumab Non-Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗非中和重组抗体(靶标：乌瑞鲁单抗非中和抗体)	469
Anti-Urelumab Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗中和重组抗体(靶标：乌瑞鲁单抗中和抗体)	465
Anti-Urelumab Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗中和重组抗体(靶标：乌瑞鲁单抗中和抗体)	466
Anti-Urelumab Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗中和重组抗体(靶标：乌瑞鲁单抗中和抗体)	413
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	187
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	303
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	474
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	158
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody \|抗雷珠单抗非中和重组抗体(靶标：雷珠单抗非中和抗体)	404
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody \|抗雷珠单抗非中和重组抗体(靶标：雷珠单抗非中和抗体)	284
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody \|抗雷珠单抗非中和重组抗体(靶标：雷珠单抗非中和抗体)	387
Anti-Ranibizumab Neutralizing Recombinant Antibody \|抗雷珠单抗中和重组抗体(靶标：雷珠单抗中和抗体)	265
Anti-Ranibizumab Neutralizing Recombinant Antibody \|抗雷珠单抗中和重组抗体(靶标：雷珠单抗中和抗体)	370
Anti-Ranibizumab Neutralizing Recombinant Antibody \|抗雷珠单抗中和重组抗体(靶标：雷珠单抗中和抗体)	180